Related Experiment Video
Updated: Jun 17, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
[Unmet needs in hypertension].
Hüseyin Altuğ Cakmak1, Eren Arslan, Serap Erdine
1Department of Cardiology, Cerrahpaşa Medicine Faculty of Istanbul University, Istanbul, Turkey.
Hypertension affects one billion people globally, with current treatments inadequately controlling blood pressure. New drugs targeting the renin-angiotensin system (RAS) aim for better control and organ damage prevention.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Pharmacology
Context:
- Hypertension is a major global health issue affecting approximately one billion individuals worldwide.
- Despite 50 years of medical advancements, hypertension control rates remain unacceptably low.
- Hypertension is a chronic condition associated with significant cardiac, vascular, and renal organ damage.
Purpose:
- To review the role of the renin-angiotensin system (RAS) in blood pressure regulation.
- To discuss the potential of novel antihypertensive drugs, particularly direct renin inhibitors, in improving blood pressure management.
- To explore strategies for preventing target organ damage in hypertensive patients.
Summary:
- The renin-angiotensin system (RAS) is a key focus in hypertension research due to its role in regulating blood pressure.
- Current antihypertensive treatments have limitations in achieving optimal blood pressure control.
- Direct renin inhibitors are being investigated for their potential to offer superior blood pressure reduction and organ protection.
Impact:
- Improved understanding of RAS in hypertension etiology.
- Potential for enhanced therapeutic strategies targeting RAS.
- Development of new antihypertensive medications to reduce cardiovascular and renal morbidity.
Related Concept Videos
Hypertension V: Nursing Management
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Hypertension IV: Drug Therapy and Lifestyle Modifications
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System